• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • Residency Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • Residency Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Public Health

Socioeconomically disadvantaged neighborhoods linked to increased rehospitalization rates

byKenan Celtik, MSandSai Folmsbee
December 2, 2014
in Public Health
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. Living in the most socioeconomically disadvantaged 15% of neighborhoods was linked to increased rate of rehospitalization for acute myocardial infarction, pneumonia and heart failure in Medicare patients.

Evidence Rating Level: 2 (Good)

Study Rundown: Rehospitalization within 30 days of discharge occurs in about 20% of Medicare admissions and costs $17 billion annually. To better target programs that address readmissions toward high-risk patients, this retrospective study compared the area deprivation index (ADI) of ZIP codes to the rates of rehospitalization for 255,744 Medicare beneficiaries. The ADI describes the socioeconomic status of US ZIP codes based on the 2000 US census data. The average rehospitalization rate for most neighborhoods was 21%, while the most disadvantaged 15% of neighborhoods had rehospitalization rates from 22% to 27%. The risk of readmission associated with the ADI of a patient’s ZIP code was linked to a similar level of risk as having chronic pulmonary disease or peripheral vascular disease and was even greater than that of being on Medicaid or being diabetic. A limitation of this study was that ADIs were based on 2000 census data and the scoring may not reflect how the socioeconomic status of neighborhoods have changed. Overall, this study suggests that ADI may be used to identify patients who may benefit from interventions to reduce rehospitalizations.

Click to read the study, published today in the Annals of Internal Medicine

Relevant Reading: Widening socioeconomic inequalities in US life expectancy, 1980–2000

In-Depth [retrospective cohort]: The study cohort consisted of 244,744 Medicare beneficiaries >65 years old hospitalized for myocardial infarction, pneumonia or heart failure. The patient characteristics and 30-day rehospitalization rates were compared to the ADI score, a multifactorial socioeconomic status indicator of the patients’ neighborhoods. Based on the percentiles of ADI scores, the risk of 30-day rehospitalization associated with living in the most disadvantaged 5% (RR 1.09, p<0.001), the 2nd most disadvantaged 5% (RR 1.07, p<0.001), and the 3rd most disadvantaged 5% (RR 1.05, p<0.01) of neighborhoods were significantly more than for people residing in the other 85%. The risk for rehospitalization associated with living in these disadvantaged neighborhoods was similar to those associated with chronic pulmonary disease (RR 1.06, p<0.001) or peripheral vascular disease (RR 1.07, p<0.001), and greater than the risks associated with being on Medicaid (RR 1.00, p<0.82) or having uncomplicated diabetes (RR 0.95, p <0.001).

RELATED REPORTS

Neighbourhood socioeconomic status may be associated with days spent at home following hip fracture in older adults

Vaporized nicotine products may be effective for smoking cessation among people with social disadvantage

More from this author: Sofosbuvir plus ledipasvir may be effective in chronic HCV after viral relapse, Multidrug induction therapy increases remission from lupus nephritis, Clinicians frequently unaware of the presence of central venous catheters, USPSTF recommends routinely screening asymptomatic women for chlamydia and gonorrhea, Key drugs reduce fracture risk in osteoporosis, Troponin use for suspected coronary syndrome limited in chronic kidney disease

Image: CC/Eyone

©2014 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. No article should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2 Minute Medicine, Inc.

Tags: readmissionsocioeconomic status
Previous Post

CXCL13 shows potential as anti-NMDA receptor encephalitis biomarker

Next Post

Tumor-specific mutant antigens are potential targets for cancer therapy [PreClinical]

RelatedReports

Bisphosphonate use and risk of atypical femur fractures
Orthopedic Surgery

Neighbourhood socioeconomic status may be associated with days spent at home following hip fracture in older adults

January 12, 2026
Vaping to quit smoking collage: a woman in a work jacket above a row of ever-shorter unlit cigarettes ending in a vape
Public Health

Vaporized nicotine products may be effective for smoking cessation among people with social disadvantage

July 14, 2025
Cardiology

Low income associated with worse cardiovascular health in middle-aged adults

December 15, 2023
Walking for health collage: a pair of walking shoes and a fitness band at the start of a winding path toward a tree
Public Health

Socioeconomic status may influence the association between physical activity and health outcomes

March 10, 2023
Next Post
Tumor-specific mutant antigens are potential targets for cancer therapy [PreClinical]

Tumor-specific mutant antigens are potential targets for cancer therapy [PreClinical]

Multiple factors may increase risk of falls in young children

Multiple factors may increase risk of falls in young children

40-year trends of net cancer survival reveal improved outcomes

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • In topline phase 3 results, nomelcitinib improved PASI 90 and PGA 0/1 responses versus placebo in plaque psoriasis
  • Intraosseous cefuroxime (Ceftin) may improve tissue delivery compared to intravenous administration during total knee arthroplasty
  • 2 Minute Medicine Rewind November 2, 2026
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • Residency Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.